Clinical Trial Update: Everolimus Monotherapy as Immunosuppression After Liver Transplant [Phase 3]

View source ↗

Summary

Phase 3 trial investigating everolimus monotherapy as immunosuppression after liver transplant was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Indiana University | Conditions: Kidney Failure | Phase 3 | Status: TERMINATED | Results posted: 2023-05-23